Drug Shortage Report for TEVA-HALOPERIDOL
| Report ID | 1841 |
| Drug Identification Number | 00363677 |
| Brand name | TEVA-HALOPERIDOL |
| Common or Proper name | HALOPERIDOL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-02-01 |
| Estimated end date | 2017-04-13 |
| Actual end date | 2017-04-17 |
| Shortage status | Resolved |
| Updated date | 2017-04-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-04-25 | French | Compare |
| v3 | 2017-04-25 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 4 of 4